Post-marketing safety surveillance of the BBIBP-CorV (Sinopharm) COVID-19 vaccine in Peruvian healthcare workers: A retrospective analysis of a Pharmacovigilance Center
Key Points
Adverse events reported included fatigue and nausea among healthcare workers, indicating potential vaccine side effects.
Data extracted from the Pharmacovigilance Center revealed significant safety signals from BBIBP-CorV vaccinations.
Retrospective analysis of vaccine administration records identified safety outcomes over a specified observation period.
Findings highlight the need for ongoing monitoring of COVID-19 vaccine safety in diverse populations.
Like
Bookmark
Share
Like
Bookmark
Share
Post-marketing safety surveillance of the BBIBP-CorV (Sinopharm) COVID-19 vaccine in Peruvian healthcare workers: A retrospective analysis of a Pharmacovigilance Center | Synapse
Cite This Study
Rodríguez-Tanta et al. (Sat,) studied this question.